×
Embecta EBITDA 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Embecta ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Embecta EBITDA 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Embecta ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$151B
CVS Health (CVS)
$87B
Elevance Health (ELV)
$69.7B
Cencora (COR)
$56.8B
DiDi Global (DIDIY)
$25.8B
Labcorp Holdings (LH)
$22.5B
Natera (NTRA)
$22.4B
BioMerieux (BMXMF)
$17.2B
EUROFINS SCIENT (ERFSF)
$15.6B
ICON (ICLR)
$14.2B
CochLear (CHEOY)
$13.4B
Medpace Holdings (MEDP)
$12.9B
Solventum (SOLV)
$12.4B
Viatris (VTRS)
$12.4B
Revvity (RVTY)
$10.5B
Caris Life Sciences,�Inc (CAI)
$10.3B
Sonic Healthcare (SKHHY)
$9.1B
Avantor (AVTR)
$8.8B
HealthEquity (HQY)
$7.8B
Charles River Laboratories (CRL)
$7.7B
Bausch + Lomb (BLCO)
$5.2B
Sotera Health (SHC)
$4.5B
BrightSpring Health Services (BTSG)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.6B
Alignment Healthcare (ALHC)
$3B
Concentras Parent (CON)
$3B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.5B
Premier (PINC)
$2.1B